# A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function

> **NCT07269301** · PHASE1 · RECRUITING · sponsor: **Pfizer** · enrollment: 26 (estimated)

## Conditions studied

- Hepatic Impairment
- Healthy

## Interventions

- **DRUG:** PF-07328948

## Key facts

- **NCT ID:** NCT07269301
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-29
- **Primary completion:** 2027-02-23
- **Final completion:** 2027-02-23
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2026-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07269301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07269301, "A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07269301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*